CLINICAL_TRIALS
withdrawal
· 2019-02-12
Clinical Trial Update: Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics [Phase 4]
Summary
A Phase 4 trial evaluating a sphenopalatine ganglion nerve block for postdural puncture headache (with cerebrospinal fluid leak) in obstetrics has been withdraw…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Washington University School of Medicine | Conditions: Postdural Puncture Headache, Cerebrospinal Fluid Leak | Phase 4 | Status: WITHDRAWN